ClinicalTrials.Veeva

Menu

The Effect of Meal Replacement on the Time to Reach the Blood Glucose Target in Patients With Type 2 Diabetes Mellitus

Sun Yat-sen University logo

Sun Yat-sen University

Status

Unknown

Conditions

Diabetes
Blood Sugar; High

Treatments

Dietary Supplement: Meal Replacement

Study type

Interventional

Funder types

Other

Identifiers

NCT05365152
2021-793

Details and patient eligibility

About

This study was designed as a randomized controlled study. It was planned to include 100 patients with type 2 diabetes who received short-term intensive insulin therapy and randomly divided them into a meal replacement intervention group and a conventional diabetes diet group according to 1:1. Both groups were treated with short-term intensive insulin therapy to control blood sugar. .

Enrollment

50 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Type 2 diabetic patients who meet the diagnosis of type 2 diabetes (CDS2020) and are willing to receive intensive insulin hypoglycemic therapy;
  2. Glycated hemoglobin A1c≥7.5%;
  3. Age between 18-70 years old, body mass index (BMI) 20-35kg/m2;
  4. Be able and willing to cooperate with diet and exercise and monitor blood sugar in accordance with the project regulations, and agree to sign the informed consent.

Exclusion criteria

  1. Diagnosed as type 1 diabetes or special type of diabetes;
  2. Allergic or intolerable to the meal replacement food used in the study;
  3. Acute complications of diabetes (including DKA, HHS, lactic acidosis)
  4. Severe microvascular complications: proliferative retinopathy; urine AER>300mg/g or urine protein positive, quantitative>0.5g/d; uncontrolled painful diabetic neuropathy and significant diabetic autonomic neuropathy;
  5. Significant macrovascular complications: patients with acute cerebrovascular accident, acute coronary syndrome, peripheral arterial disease requiring vascular intervention or amputation within 12 months before enrollment;
  6. Serum creatinine clearance rate is less than 50ml/min/1.73m2 (calculated according to CKDEPI formula), alanine aminotransferase ≥ 3 times the upper limit of normal, and total bilirubin ≥ 2 times the upper limit of normal;
  7. The cumulative time of using drugs that may affect blood sugar for more than 1 week within 12 weeks, such as oral/intravenous glucocorticoids, GH, estrogen/progestin, high-dose diuretics, antipsychotics, etc.;
  8. Systemic infection or serious concomitant diseases; patients with malignant tumors or chronic diarrhea;
  9. Uncontrolled endocrine gland dysfunction;
  10. Mental or communication disorders;
  11. Pregnant and lactating women;
  12. The subject is not cooperative, or the investigator judges that it may be difficult to complete the investigator;
  13. Other circumstances judged by the investigator to be unsuitable for inclusion.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

Meal replacement intervention group
Experimental group
Description:
On the day of the patient's admission, the total calories required for the diabetic diet during the hospitalization period were calculated according to "ideal weight \* 25/kcal" (BMI \> 28, 80% of this value). Carbohydrates, fats, and proteins accounted for 50%, 30%, and 20% of the energy supply, respectively, and the calories of the three meals were distributed according to 1:2:2. The meal replacement intervention group replaced the daily meal with meal replacement on the basis of the conventional diabetic diet. About 400kcal calories in carbohydrates.
Treatment:
Dietary Supplement: Meal Replacement
diabetes diet group
No Intervention group
Description:
On the day of the patient's admission, the total calories required for the diabetic diet during the hospitalization period were calculated according to "ideal weight \* 25/kcal" (BMI \> 28, 80% of this value). Carbohydrates, fats, and proteins accounted for 50%, 30%, and 20% of the energy supply, respectively, and the calories of the three meals were distributed according to 1:2:2.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems